These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 30907318)
21. Acetylation as a major determinant to microtubule-dependent autophagy: Relevance to Alzheimer's and Parkinson disease pathology. Esteves AR; Palma AM; Gomes R; Santos D; Silva DF; Cardoso SM Biochim Biophys Acta Mol Basis Dis; 2019 Aug; 1865(8):2008-2023. PubMed ID: 30572013 [TBL] [Abstract][Full Text] [Related]
22. Acetylation and phosphorylation processes modulate Tau's binding to microtubules: A molecular dynamics study. Castro TG; Ferreira T; Matamá T; Munteanu FD; Cavaco-Paulo A Biochim Biophys Acta Gen Subj; 2023 Feb; 1867(2):130276. PubMed ID: 36372288 [TBL] [Abstract][Full Text] [Related]
23. Can any "non-specific charge modification within microtubule binding domains of Tau" be a prerequisite of the protein amyloid aggregation? An in vitro study on the 1N4R isoform. Jangholi A; Ashrafi-Kooshk MR; Arab SS; Karima S; Poorebrahim M; Ghadami SA; Moosavi-Movahedi AA; Khodarahmi R Int J Biol Macromol; 2018 Apr; 109():188-204. PubMed ID: 29248553 [TBL] [Abstract][Full Text] [Related]
24. An acetylation mimicking mutation, K274Q, in tau imparts neurotoxicity by enhancing tau aggregation and inhibiting tubulin polymerization. Rane JS; Kumari A; Panda D Biochem J; 2019 May; 476(10):1401-1417. PubMed ID: 31036717 [TBL] [Abstract][Full Text] [Related]
25. Amyloidogenesis of Tau protein. Nizynski B; Dzwolak W; Nieznanski K Protein Sci; 2017 Nov; 26(11):2126-2150. PubMed ID: 28833749 [TBL] [Abstract][Full Text] [Related]
26. Posttranslational modifications of tau--role in human tauopathies and modeling in transgenic animals. Chen F; David D; Ferrari A; Götz J Curr Drug Targets; 2004 Aug; 5(6):503-15. PubMed ID: 15270197 [TBL] [Abstract][Full Text] [Related]
27. A validated antibody panel for the characterization of tau post-translational modifications. Ercan E; Eid S; Weber C; Kowalski A; Bichmann M; Behrendt A; Matthes F; Krauss S; Reinhardt P; Fulle S; Ehrnhoefer DE Mol Neurodegener; 2017 Nov; 12(1):87. PubMed ID: 29157277 [TBL] [Abstract][Full Text] [Related]
28. Altered tubulin assembly dynamics with N-homocysteinylated human 4R/1N tau in vitro. Karima O; Riazi G; Khodadadi S; Aryapour H; Khalili MA; Yousefi L; Moosavi-Movahedi AA FEBS Lett; 2012 Nov; 586(21):3914-9. PubMed ID: 23041345 [TBL] [Abstract][Full Text] [Related]
29. Critical residues involved in tau binding to fyn: implications for tau phosphorylation in Alzheimer's disease. Lau DH; Hogseth M; Phillips EC; O'Neill MJ; Pooler AM; Noble W; Hanger DP Acta Neuropathol Commun; 2016 May; 4(1):49. PubMed ID: 27193083 [TBL] [Abstract][Full Text] [Related]
30. Acetylated tau destabilizes the cytoskeleton in the axon initial segment and is mislocalized to the somatodendritic compartment. Sohn PD; Tracy TE; Son HI; Zhou Y; Leite RE; Miller BL; Seeley WW; Grinberg LT; Gan L Mol Neurodegener; 2016 Jun; 11(1):47. PubMed ID: 27356871 [TBL] [Abstract][Full Text] [Related]
31. HDAC6 inhibition results in tau acetylation and modulates tau phosphorylation and degradation in oligodendrocytes. Noack M; Leyk J; Richter-Landsberg C Glia; 2014 Apr; 62(4):535-47. PubMed ID: 24464872 [TBL] [Abstract][Full Text] [Related]
34. Tauopathy: A common mechanism for neurodegeneration and brain aging. Saha P; Sen N Mech Ageing Dev; 2019 Mar; 178():72-79. PubMed ID: 30668956 [TBL] [Abstract][Full Text] [Related]
35. Critical role of acetylation in tau-mediated neurodegeneration and cognitive deficits. Min SW; Chen X; Tracy TE; Li Y; Zhou Y; Wang C; Shirakawa K; Minami SS; Defensor E; Mok SA; Sohn PD; Schilling B; Cong X; Ellerby L; Gibson BW; Johnson J; Krogan N; Shamloo M; Gestwicki J; Masliah E; Verdin E; Gan L Nat Med; 2015 Oct; 21(10):1154-62. PubMed ID: 26390242 [TBL] [Abstract][Full Text] [Related]
36. Accumulated amyloid-beta peptide and hyperphosphorylated tau protein: relationship and links in Alzheimer's disease. Huang HC; Jiang ZF J Alzheimers Dis; 2009; 16(1):15-27. PubMed ID: 19158417 [TBL] [Abstract][Full Text] [Related]
37. Disease-associated patterns of acetylation stabilize tau fibril formation. Li L; Nguyen B; Mullapudi V; Saelices L; Joachimiak LA bioRxiv; 2023 Jan; ():. PubMed ID: 36711822 [TBL] [Abstract][Full Text] [Related]
38. Tau stabilizes microtubules by binding at the interface between tubulin heterodimers. Kadavath H; Hofele RV; Biernat J; Kumar S; Tepper K; Urlaub H; Mandelkow E; Zweckstetter M Proc Natl Acad Sci U S A; 2015 Jun; 112(24):7501-6. PubMed ID: 26034266 [TBL] [Abstract][Full Text] [Related]
39. Structural and functional implications of tau hyperphosphorylation: information from phosphorylation-mimicking mutated tau proteins. Eidenmüller J; Fath T; Hellwig A; Reed J; Sontag E; Brandt R Biochemistry; 2000 Oct; 39(43):13166-75. PubMed ID: 11052669 [TBL] [Abstract][Full Text] [Related]
40. Ser Sandhu P; Naeem MM; Lu C; Kumarathasan P; Gomes J; Basak A Bioorg Med Chem Lett; 2017 Feb; 27(3):642-652. PubMed ID: 27989667 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]